| RS1167329263 |
PKLR
|
Health Risk |
Likely pathogenic |
PKLR-related disorder, PKLR-related disorder |
| RS116733194 |
DYSF
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2B, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS116733939 |
RDH12
|
Health Risk |
Pathogenic |
Leber congenital amaurosis, Leber congenital amaurosis 13 |
| RS1167362899 |
TSC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 1, Hereditary cancer-predisposing syndrome |
| RS116736407 |
FANCD2
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia, FANCD2-related disorder |
| RS1167372383 |
ARID1A
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1167380267 |
FAM161A
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinal dystrophy, Retinitis pigmentosa 28 |
| RS1167384081 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1167385983 |
UNC93B1
|
Health Risk |
Pathogenic |
Herpes simplex encephalitis, susceptibility to |
| RS1167386243 |
CREB3L3
|
Health Risk |
Pathogenic |
Hypertriglyceridemia 2, Hypertriglyceridemia 2 |
| RS116740320 |
TTC8
|
Health Risk |
Conflicting classifications of pathogenicity |
Bardet-Biedl syndrome 8, Retinitis pigmentosa |
| RS116740510 |
KCNJ13;GIGYF2
|
Health Risk |
Conflicting classifications of pathogenicity |
Leber congenital amaurosis 16, Leber congenital amaurosis 16 |
| RS1167405466 |
NOTCH3
|
Health Risk |
Pathogenic/Likely pathogenic |
Cerebral arteriopathy, autosomal dominant |
| RS1167407832 |
COL18A1
|
Health Risk |
Likely pathogenic |
— |
| RS1167411352 |
COL4A3
|
Health Risk |
Pathogenic |
Autosomal dominant Alport syndrome, Alport syndrome 3b |
| RS1167411868 |
PRX
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease, Charcot-Marie-Tooth disease type 4 |
| RS1167413684 |
ENPP1
|
Health Risk |
Pathogenic |
Arterial calcification, generalized |
| RS116744687 |
NPHS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital nephrotic syndrome, Congenital nephrotic syndrome |
| RS1167452184 |
LZTR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Hereditary cancer-predisposing syndrome |
| RS1167453314 |
CC2D2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Joubert syndrome, Meckel-Gruber syndrome |
| RS1167455690 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS1167459243 |
KCND3
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Spinocerebellar ataxia type 19/22 |
| RS1167459660 |
ARSB
|
Health Risk |
Likely pathogenic |
Mucopolysaccharidosis type 6, Mucopolysaccharidosis type 6 |
| RS1167469350 |
VCAN
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1167473603 |
CYP4F22
|
Health Risk |
Pathogenic |
Autosomal recessive congenital ichthyosis 5, Autosomal recessive congenital ichthyosis 5 |
| RS1167474602 |
SACS
|
Health Risk |
Pathogenic/Likely pathogenic |
Charlevoix-Saguenay spastic ataxia, Spastic paraplegia |
| RS1167476946 |
PKD1
|
Health Risk |
Likely pathogenic |
Polycystic kidney disease, adult type |
| RS1167489264 |
SP110
|
Health Risk |
Conflicting classifications of pathogenicity |
Hepatic veno-occlusive disease-immunodeficiency syndrome, Hepatic veno-occlusive disease-immunodeficiency syndrome |
| RS1167495153 |
SCN5A
|
Health Risk |
Likely pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS1167495795 |
PRPF6
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Retinal dystrophy |
| RS116750302 |
RELN
|
Health Risk |
Conflicting classifications of pathogenicity |
Norman-Roberts syndrome, Familial temporal lobe epilepsy 7 |
| RS116750638 |
MTMR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 4, Charcot-Marie-Tooth disease |
| RS1167507020 |
RARS2
|
Health Risk |
Likely pathogenic |
Pontocerebellar hypoplasia type 6, Pontocerebellar hypoplasia type 6 |
| RS1167512470 |
SLC52A3
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1167519702 |
DNAH11
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1167522067 |
ABCA3
|
Health Risk |
Pathogenic |
— |
| RS116753562 |
COL6A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS1167538050 |
MAX
|
Health Risk |
Pathogenic |
Hereditary pheochromocytoma and paraganglioma, Hereditary cancer-predisposing syndrome |
| RS116753967 |
STRA6
|
Health Risk |
Conflicting classifications of pathogenicity |
Matthew-Wood syndrome, Matthew-Wood syndrome |
| RS1167540054 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Usher syndrome, Retinitis pigmentosa 39 |
| RS1167571128 |
REN
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS116757606 |
ANK3
|
Health Risk |
Conflicting classifications of pathogenicity |
ANK3-related disorder, ANK3-related disorder |
| RS116758113 |
XPNPEP3
|
Health Risk |
Conflicting classifications of pathogenicity |
Kidney disorder, Nephronophthisis-like nephropathy 1 |
| RS1167604511 |
KIF1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Neuropathy |
| RS116760648 |
COL6A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS1167608859 |
MPZL2
|
Health Risk |
Pathogenic/Likely pathogenic |
Hearing loss, autosomal recessive 111 |
| RS1167609100 |
STK11
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Peutz-Jeghers syndrome |
| RS1167613754 |
CNGB1
|
Health Risk |
Likely pathogenic |
— |
| RS116763572 |
FREM2
|
Health Risk |
Conflicting classifications of pathogenicity |
Fraser syndrome 2, FREM2-related disorder |
| RS1167652701 |
TSC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 1, Hereditary cancer-predisposing syndrome |
| RS116765281 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS1167673455 |
VCAN
|
Health Risk |
Pathogenic |
— |
| RS1167675604 |
GCK
|
Health Risk |
Pathogenic |
Maturity-onset diabetes of the young type 2, Monogenic diabetes |
| RS1167687731 |
COL6A2
|
Health Risk |
Likely pathogenic |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS1167693193 |
PTCH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Gorlin syndrome, Hereditary cancer-predisposing syndrome |
| RS1167697962 |
KBTBD13
|
Health Risk |
Conflicting classifications of pathogenicity |
Nemaline myopathy 6, Inborn genetic diseases |
| RS116771294 |
ZMPSTE24
|
Health Risk |
Conflicting classifications of pathogenicity |
Mandibuloacral dysplasia with type B lipodystrophy, Mandibuloacral dysplasia with type B lipodystrophy |
| RS1167715259 |
ASXL1
|
Health Risk |
Pathogenic |
ASXL1-related disorder, ASXL1-related disorder |
| RS1167718207 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome |
| RS1167718213 |
RRM2B
|
Health Risk |
Likely pathogenic |
— |
| RS116772777 |
PIGG
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, autosomal recessive 53 |
| RS116774070 |
DST
|
Health Risk |
Conflicting classifications of pathogenicity |
Epidermolysis bullosa simplex 3, localized or generalized intermediate |
| RS1167742176 |
EYS
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1167753426 |
RYR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Catecholaminergic polymorphic ventricular tachycardia 1 |
| RS116775353 |
CFAP61
|
Health Risk |
Pathogenic |
Spermatogenic failure 84, Spermatogenic failure 84 |
| RS1167765853 |
AGRN
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder, Neurodevelopmental disorder |
| RS1167783894 |
FAH
|
Health Risk |
Likely pathogenic |
Tyrosinemia type I, Tyrosinemia type I |
| RS1167787806 |
GRIN2D
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1167794021 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1167814155 |
ALS2
|
Health Risk |
Pathogenic |
Infantile-onset ascending hereditary spastic paralysis, Infantile-onset ascending hereditary spastic paralysis |
| RS1167814744 |
SLC4A1
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS116781972 |
GATA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Atrioventricular septal defect 4, Cardiovascular phenotype |
| RS1167826982 |
TPO
|
Health Risk |
Conflicting classifications of pathogenicity |
Deficiency of iodide peroxidase, Deficiency of iodide peroxidase |
| RS1167848259 |
EMC1
|
Health Risk |
Pathogenic |
— |
| RS1167864898 |
NIN
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1167867158 |
CRB1
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinal dystrophy, Leber congenital amaurosis 8 |
| RS1167872104 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS116788608 |
PMS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Lynch syndrome 1 |
| RS1167886830 |
AMT
|
Health Risk |
Likely pathogenic |
Glycine encephalopathy, Glycine encephalopathy 1 |
| RS1167894918 |
NEB
|
Health Risk |
Conflicting classifications of pathogenicity |
Nemaline myopathy 2, Inborn genetic diseases |
| RS1167901073 |
HPDL
|
Health Risk |
Likely pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS1167911121 |
DNAH5
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1167914907 |
LCT
|
Health Risk |
Pathogenic |
— |
| RS116791509 |
SACS
|
Health Risk |
Conflicting classifications of pathogenicity |
Spastic paraplegia, Charlevoix-Saguenay spastic ataxia |
| RS1167920036 |
COL4A5
|
Health Risk |
Likely pathogenic |
— |
| RS1167928854 |
LMF1
|
Health Risk |
Pathogenic |
— |
| RS116794756 |
COL6A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Collagen 6-related myopathy, Bethlem myopathy 1A |
| RS116796597 |
VPS13D
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1167979935 |
RDH12
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 13, Leber congenital amaurosis 13 |
| RS1167983525 |
MYO7A
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1167993548 |
ABCC8
|
Health Risk |
Likely pathogenic |
Hyperinsulinemic hypoglycemia, familial |
| RS116800126 |
CD46
|
Health Risk |
Conflicting classifications of pathogenicity |
Atypical hemolytic-uremic syndrome with MCP/CD46 anomaly, Atypical hemolytic-uremic syndrome |
| RS116802390 |
RDH12
|
Health Risk |
Conflicting classifications of pathogenicity |
Leber congenital amaurosis 13, Retinal dystrophy |
| RS1168030930 |
EDA
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypohidrotic X-linked ectodermal dysplasia, Hypohidrotic X-linked ectodermal dysplasia |
| RS1168031047 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Tuberous sclerosis 2 |
| RS1168034376 |
AEBP1
|
Health Risk |
Pathogenic |
— |
| RS116803472 |
VPS13C
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1168053730 |
OTC
|
Health Risk |
Conflicting classifications of pathogenicity |
Ornithine carbamoyltransferase deficiency, Inborn genetic diseases |
| RS116805550 |
BBS12
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, BBS12-related disorder |
| RS1168074679 |
CUBN
|
Health Risk |
Pathogenic |
Imerslund-Grasbeck syndrome, Imerslund-Grasbeck syndrome |